These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6977559)

  • 1. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
    Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
    J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of labeled triethanolamine salicylate in human and canine knee joints. II.
    Rabinowitz JL; Baker D
    J Clin Pharmacol; 1984; 24(11-12):532-9. PubMed ID: 6334699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of salicylates from blood to joint fluid.
    Soren A
    Arch Intern Med; 1973 Nov; 132(5):668-72. PubMed ID: 4750223
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats.
    Megwa SA; Benson HA; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):891-6. PubMed ID: 8708981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentisate, a salicylate metabolite with antioxidant properties.
    Cleland LG; Whitehouse MW; Betts WH
    Drugs Exp Clin Res; 1985; 11(8):463-7. PubMed ID: 3879751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative pharmacokinetics of salicylic acids administered orally and topically on the skin].
    Gawrońska-Szklarz B; Górnik W; Kustroń B; Wójcicki J; Samochowiec L
    Pol Tyg Lek; 1983 Apr; 38(17):525-7. PubMed ID: 6634501
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kinetics of salicylates from the blood to the articular fluid].
    Soren A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):165-9. PubMed ID: 653293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of a topically applied nonsteroidal anti-inflammatory drug into local tissues and synovial fluid of dogs.
    Mills PC; Magnusson BM; Cross SE
    Am J Vet Res; 2005 Jul; 66(7):1128-32. PubMed ID: 16111149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin.
    Greenblatt DJ; Abernethy DR; Boxenbaum HG; Matlis R; Ochs HR; Harmatz JS; Shader RI
    Arthritis Rheum; 1986 Aug; 29(8):971-80. PubMed ID: 3741521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration.
    Dominkus M; Nicolakis M; Kotz R; Wilkinson FE; Kaiser RR; Chlud K
    Arzneimittelforschung; 1996 Dec; 46(12):1138-43. PubMed ID: 9006788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy.
    Rolf C; Engström B; Beauchard C; Jacobs LD; Le Liboux A
    Rheumatology (Oxford); 1999 Jun; 38(6):564-7. PubMed ID: 10402079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time for salicylate diffusion from blood to joint fluid. A study of histopathology of the synovial membrane.
    Soren A
    Reumatismo; 1977; 29(1):1-6. PubMed ID: 618099
    [No Abstract]   [Full Text] [Related]  

  • 17. Skin and plasma levels of acetylsalicylic acid: a comparison between topical aspirin/diethyl ether mixture and oral aspirin in acute herpes zoster and postherpetic neuralgia.
    Bareggi SR; Pirola R; De Benedittis G
    Eur J Clin Pharmacol; 1998 May; 54(3):231-5. PubMed ID: 9681665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.
    Cross SE; Megwa SA; Benson HA; Roberts MS
    Pharm Res; 1999 Mar; 16(3):427-33. PubMed ID: 10213375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of plateau serum salicylate level with rate of salicylate metabolism.
    Gupta N; Sarkissian E; Paulus HE
    Clin Pharmacol Ther; 1975 Sep; 18(3):350-5. PubMed ID: 1100304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.